Literature DB >> 10739903

Structural changes of atrial myocardium during chronic atrial fibrillation.

V L Thijssen1, J Ausma, G S Liu, M A Allessie, G J van Eys, M Borgers.   

Abstract

Of all known arrhythmia's, atrial fibrillation (AF) is the most often met in the clinical setting and it is associated with an increase in mortality risk. Several risk factors for AF have been described and several mechanisms of induction and maintenance have been proposed. Studies in patients with AF have shown that structural changes occur in the atria, but the relationship between the structural remodelling and the chronicity of the arrhythmia are not well understood. The changes mainly concern adaptive (dedifferentiation of cardiomyocytes) and maladaptive (degeneration of cells with replacement fibrosis) features. In order to characterise the time course of the structural remodelling the need for animal models which adequately mimic chronic atrial fibrillation in humans is felt essential. In this review, the structural changes that are observed during prolonged sustained AF in patients and animal models, are described. Furthermore, the time course and potential mechanisms of structural remodelling are discussed and methods for elucidation of the underlying molecular mechanisms are presented.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10739903     DOI: 10.1016/s1054-8807(99)00038-1

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  29 in total

Review 1.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 2.  Proteomics and transcriptomics in atrial fibrillation.

Authors:  Marc Sühling; Carmen Wolke; Christian Scharf; Uwe Lendeckel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-01-09

Review 3.  Alterations in atrial perfusion during atrial fibrillation.

Authors:  Christina F Pacchia; Derek J Dosdall; Ravi Ranjan; Edward DiBella
Journal:  Exp Physiol       Date:  2014-07-25       Impact factor: 2.969

Review 4.  Molecular and cellular basis of viable dysfunctional myocardium.

Authors:  Marina Bayeva; Konrad Teodor Sawicki; Javed Butler; Mihai Gheorghiade; Hossein Ardehali
Journal:  Circ Heart Fail       Date:  2014-07       Impact factor: 8.790

Review 5.  Myocardial Ischemia as a Genuine Cause Responsible for the Organization and "Fertilization" of Conflictogenic Atrial Fibrillation:New Conceptual Insights Into Arrhythmogenicity.

Authors:  Petras Stirbys
Journal:  J Atr Fibrillation       Date:  2013-04-06

6.  Role for myosin-V motor proteins in the selective delivery of Kv channel isoforms to the membrane surface of cardiac myocytes.

Authors:  Sarah M Schumacher-Bass; Eileen D Vesely; Lian Zhang; Katherine E Ryland; Dyke P McEwen; Priscilla J Chan; Chad R Frasier; Jeremy C McIntyre; Robin M Shaw; Jeffrey R Martens
Journal:  Circ Res       Date:  2014-02-07       Impact factor: 17.367

Review 7.  Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.

Authors:  Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-26       Impact factor: 3.000

8.  Role of magnetic resonance imaging in atrial fibrillation ablation.

Authors:  Roy Beinart; Saman Nazarian
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-06

Review 9.  Patient-specific flexible and stretchable devices for cardiac diagnostics and therapy.

Authors:  Sarah R Gutbrod; Matthew S Sulkin; John A Rogers; Igor R Efimov
Journal:  Prog Biophys Mol Biol       Date:  2014-08-05       Impact factor: 3.667

Review 10.  Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation.

Authors:  Gerald V Naccarelli; Frank Peacock
Journal:  Vasc Health Risk Manag       Date:  2009-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.